Drug intelligence / Profile preview

cephalexin + metronidazole

Development stage
Unknown
Lead developer
Eli Lilly
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Cephalexin + metronidazole is a combination of two antibiotics used together to treat mixed bacterial infections, particularly those involving both aerobic and anaerobic bacteria. Cephalexin is a first-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, primarily targeting gram-positive organisms. Metronidazole is a nitroimidazole antibiotic effective against anaerobic bacteria and certain protozoa; it works by disrupting DNA synthesis in susceptible organisms. This combination may be used empirically for polymicrobial infections such as intra-abdominal or pelvic infections where both aerobic and anaerobic pathogens are suspected[4][5][6]. The drugs act via distinct mechanisms, providing broad-spectrum antibacterial coverage.

02

Targets

NeuraminidasePBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on cephalexin + metronidazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cephalexin + metronidazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call